Coralan 7.5mg Tablet
Marketer
Servier India Private Limited
Salt Composition
Ivabradine (7.5mg)
Overview Coralan 7.5mg Tablet
Cardoxin 7.5mg tablets treat angina pectoris (chest pain stemming from heart issues) and persistent heart failure. Its mechanism improves cardiac efficiency by reducing heart rate, thus easing chest discomfort and minimizing hospitalizations in heart failure cases. Dosage varies based on the specific condition. As treatment for angina or heart failure is generally lifelong, discontinuation requires physician consultation. Administer with food daily at the same time. Overdosage can lead to excessive bradycardia, fatigue, and shortness of breath; seek immediate medical advice if this occurs. Common side effects include transient visual disturbances, bradycardia, hypertension, atrial fibrillation, vertigo, blurred vision, and electrocardiographic alterations. Serious adverse events like syncope and significant cardiac rhythm changes necessitate urgent medical attention. Refrain from driving until the drug's effects are known. Cardoxin 7.5mg tablets are contraindicated in patients with severe hepatic impairment, resting bradycardia, cardiac arrhythmias, significantly low blood pressure, or recently exacerbated heart failure. This medication interacts with certain antihypertensives, antifungals, and antiretrovirals. Its use is prohibited during pregnancy, attempts at conception, and lactation.
Primary Ingredients of Coralan 7.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Coralan 7.5mg Tablet
Management of angina pectoris (chest pain of cardiac origin) | Management of congestive heart failure
Major Benefits of Coralan 7.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 7.5mg Coralan tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
Common Side effects of Coralan 7.5mg Tablet:
- Slow heart rate
- Luminous phenomena (Enhanced brightness)
- High blood pressure
- Atrial fibrillation
- Dizziness
- Blurred vision
- ECG changes
How to use Coralan 7.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 7.5mg Coralan tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.
How Coralan 7.5mg Tablet works:
Lanoxin 7.5mg tablets decrease cardiac function rate. This action reduces the heart's oxygen demand, leading to improved cardiac efficiency.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of consuming alcohol while taking Coralan 7.5mg tablets is undetermined. Seek medical advice before combining them.
PregnancyUNSAFE
Pregnant individuals should absolutely avoid Coralan 7.5mg tablets. Research in both animals and pregnant women reveals substantial risks to the fetus; consult a physician before use.
Breast feedingUNSAFE
Lactation and Coralan 7.5mg tablets are incompatible. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Coralan 7.5mg Tablet side effects. These side effects may include temporary visual disturbances, primarily characterized by phosphenes. Night driving, in particular, warrants consideration of this potential visual effect.
KidneyCAUTION
Patients with severe kidney impairment should use Coralan 7.5mg Tablets cautiously, as dose modification may be necessary. Physician consultation is advised. Data on Coralan 7.5mg Tablet use in such patients is limited.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Coralan 7.5mg tablets; dosage modification may be necessary. Consult a physician for guidance. Coralan 7.5mg tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Coralan 7.5mg Tablet :
Omit any missed Coralan 7.5mg Tablet dose and resume your regular medication schedule. Avoid taking a double dose.
Facts to Know About Coralan 7.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzazepine-based compound |
| Developing Habits | No. |
| Treatment Category | HEART |
| Actions | Sinoatrial node I<sub>f</sub> sodium channel blockers |






